Admission rates during the coronavirus disease 2019 (COVID-19) pandemic were lower than in 2019 for acute medical conditions, suggesting that patients may be deferring necessary medical care.
ABSTRACT
Objectives: To determine whether patients are deferring necessary care for urgent conditions during the coronavirus disease 2019 (COVID-19) pandemic and, if so, to what extent.
Study Design: Cross-sectional study.
Methods: Using billing data from 8 acute care hospitals, we identified 9 principal medical diagnoses from International Classification of Diseases, Tenth Revision codes across 4 medical specialties (cardiology, gastroenterology, neurology, and urology). In addition, we defined a combined obstetrical falsification end point. We compared daily admission rates during the pandemic period (3/1/2020-4/30/2020) with the same dates in 2019 (3/1/2019-4/30/2019). As a reference, we also compared a prepandemic period in the same years (1/1/2019-2/28/2019 and 1/1/2020-2/29/2020). We compared admission rates between years using t tests.
Results: There were 3219 admissions for the conditions of interest during the study period in 2019 and 2661 in 2020. There was no difference in prepandemic daily admission rates in 2020 compared with 2019 (29.04 vs 27.63 admissions per day; –4.9%; P = .50). During the pandemic period, there was a 33.7% decrease in admission rates for all conditions combined in 2020 compared with 2019 (24.68 vs 16.37; –33.7%; P = .03). By specialty, the combined gastroenterology (10.22 vs 7.20; –29.6%; P = .02) and cardiovascular (2.34 vs 1.29; –44.7%; P = .05) end points demonstrated reduction in daily admission rates.
Conclusions: Daily admission rates during the COVID-19 pandemic were lower for these acute medical conditions. Public awareness campaigns are urgently needed to reassure the public about the safety of presenting for care.
Am J Manag Care. 2020;26(8):327-328. https://doi.org/10.37765/ajmc.2020.43837
Patients may be avoiding medical facilities during the coronavirus disease 2019 (COVID-19) pandemic.1,2 Whether patients are deferring needed care for urgent conditions and to what extent are unknown. We compared admission rates for acute medical conditions during the COVID-19 pandemic with a reference year.
METHODS
We used billing data from 8 acute care hospitals within a major integrated health system. We selected medical conditions for which incidence should not be affected by COVID-19. We identified 9 principal diagnoses from International Classification of Diseases, Tenth Revision codes across 4 specialties: cardiovascular disease (ST-segment elevation myocardial infarction [STEMI], aortic dissection), neurology (cerebrovascular accident, seizure), gastroenterology (appendicitis, cholecystitis, pancreatitis, gastrointestinal bleed), and urology (urolithiasis). In addition, we defined a combined obstetrical falsification end point (ectopic pregnancies, miscarriages, vaginal deliveries, and cesarean sections).
We compared daily admission rates during the pandemic period (3/1/2020-4/30/2020) with the same dates in 2019 (3/1/2019-4/30/2019). As a reference, we also compared a prepandemic period in the same years (1/1/2019-2/28/2019 and 1/1/2020-2/29/2020). We compared admission rates between years using t tests. We also describe basic demographic data for both 2019 and 2020. This project was undertaken as a Quality Improvement Initiative at Mass General Brigham and as such was not formally supervised by the Institutional Review Board per its policies.
RESULTS
There were 3219 admissions for the conditions of interest during the study period in 2019 and 2661 in 2020. In 2020, patients were 73.4% white, 53.4% male, and 86.8% English speaking, and 60.0% were older than 60 years; 41.5% were Medicare beneficiaries. There was no difference in prepandemic daily admission rates in 2020 compared with 2019 (29.04 vs 27.63 admissions per day; –4.9%; P = .50) (Table). During the pandemic period, there was a 33.7% decrease in admission rates for all conditions combined in 2020 compared with 2019 (24.68 vs 16.37; –33.7%; P = .03). By specialty, the combined gastroenterology (10.22 vs 7.20; –29.6%; P = .02) and cardiovascular (2.34 vs 1.29; –44.7%; P = .05) end points showed reduction in daily admission rates. In condition-specific analyses, cholecystitis (3.44 vs 2.10; –38.9; P = .06), gastrointestinal bleed (3.35 vs 2.37; –29.2%; P = .08), and aortic dissection (1.36 vs 0.54; –60.3%; P = .12) showed a trend toward difference. There was no difference in admission volume for the falsification end point (48.3 vs 45.6; –5.5%; P = .81).
DISCUSSION
Daily admission rates during the COVID-19 pandemic were lower for these acute medical conditions. Although combined specialty end points exhibited a decrease in daily admissions, the individual conditions were likely underpowered to identify similar changes. STEMI had an effect estimate similar in magnitude to that found in previous studies, and other conditions demonstrated a trend toward difference.1,3
The observational design limits our ability to draw causal conclusions. One explanation for these findings is that patients are fearful of engaging with medical facilities during the pandemic. Alternatively, changes in emergency department practices may result in fewer admissions or in admissions under different primary diagnosis codes related to COVID-19.
CONCLUSIONS
Because a change in incidence is unlikely for these conditions on clinical grounds, these results raise the possibility that patients are not presenting for necessary care. Public awareness campaigns are urgently needed to reassure the public about the safety of presenting for care.
Author Affiliations: Cardiology Division, Department of Medicine, Massachusetts General Hospital (ASO, JHW), Boston, MA; Data and Analytics Organization, Partners Healthcare (DN, CK, SM, PYL, JP), Boston, MA; Division of General Internal Medicine, Department of Health Care Policy, Brigham and Women’s Hospital, Harvard Medical School (TDS), Boston, MA.
Source of Funding: None.
Author Disclosures: Ms Nash, Ms Kim, and Ms Moisuk are employed with Partners Healthcare. Dr Wasfy is employed with Massachusetts General Hospital. The remaining authors report no relationship or financial interest with any entity that would pose a conflict of interest with the subject matter of this article.
Authorship Information: Concept and design (ASO, DN, JP, TDS, JHW); acquisition of data (DN, CK, SM, JP, TDS); analysis and interpretation of data (DN, CK, SM, PYL, JP, JHW); drafting of the manuscript (ASO, JHW); critical revision of the manuscript for important intellectual content (ASO, TDS, JHW); statistical analysis (DN, CK, SM, PYL, JHW); administrative, technical, or logistic support (PYL, JP, JHW); and supervision (PYL, JP, TDS, JHW).
Address Correspondence to: Jason H. Wasfy, MD, MPhil, Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114. Email: jwasfy@mgh.harvard.edu.
REFERENCES
1. Garcia S, Albaghdadi MS, Meraj PM, et al. Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic. J Am Coll Cardiol. 2020;75(22):2871-2872. doi:10.1016/j.jacc.2020.04.011
2. Rosenbaum L. The untold toll—the pandemic’s effects on patients without Covid-19. N Engl J Med. Published online April 17, 2020. doi:10.1056/NEJMms2009984
3. Rodríguez-Leor O, Cid-Álvarez B, Ojeda S, et al; Registro de Código Infarto de la ACI-SEC. Impacto de la pandemia de COVID-19 sobre la actividad asistencial en cardiología intervencionista en España. REC Interv Cardiol. 2020;2:82-89. doi:10.24875/RECIC.M20000120
Insurance Payer Is Associated With Length of Stay After Traumatic Brain Injury
February 21st 2025Among hospitalized patients with traumatic brain injury, Medicaid fee-for-service was associated with longer hospital stays than private insurance and Medicaid managed care organizations.
Read More
Managed Care Reflections: Insights From Richard J. Gilfillan, MD; and Donald M. Berwick, MD, MPP
February 20th 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes reflections from a thought leader on what has changed over the past 3 decades and what’s next for managed care. The February issue features a retrospective by Richard J. Gilfillan, MD, former director of the Center for Medicare and Medicaid Innovation; and Donald M. Berwick, MD, MPP, former administrator of CMS.
Read More
Medical Policy Determinations for Pharmacogenetic Tests Among US Health Plans
February 10th 2025This analysis demonstrated significant variability in medical policy determinations and evidence cited for clinically relevant pharmacogenetic tests among major US health insurers and laboratory benefit managers.
Read More